Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

W009 - Hands-on: Practical Anatomy for Dermal Fillers

Monday, February 19; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify structural and functional facial anatomy relevant to filler injections.
  • Utilize proper techniques for soft tissue augmentation pan-facially.
  • Implement peri-procedural assessment and strategies for avoidance and management of complications.


This hands-on training session for dermal fillers will begin with a video review of anatomy presented by Dr. Braz. Participants will then break into groups of beginner/intermediate or intermediate/advanced injectors. Faculty will circulate through each of stations focused on a specific anatomical region of the face. Each demonstration table will be equipped with high fidelity cutaneous surgical training models for practice injections using both needles and cannulas. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.


  • Braz, Andre, MD: Allergan, Inc – A(H), SP(H); Merz Pharmaceuticals, LLC – SP(Fees);
  • Butterwick, Kimberly J., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(H); Colorescience – A(H); Galderma Laboratories, L.P. – A(H), I(Grants/Research Funding); Histogen Inc. – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – A(H); Revance Therapeutics, Inc. – A(H); Sinclair Pharma, LLC – Speaker/Faculty Education(H);
  • Chiu, Annie, MD: Aclaris Therapeutics Inc. – SP(H); Allergan, Inc. – A(H), C(Fees), I(Grants/Research Funding); Boots – SP(Fees); BTL Industries – SP(H); Evolus, Inc. – A(H); La Roche-Posay Laboratorie Pharmaceutique – C(Fees); Merz Aesthetics – A(Fees); Ortho Dermatologics – SP(H); Revance Therapeutics, Inc. – A(H); SkinCeuticals LLC – A(Fees); SkinMedica, Inc. – SP(H); Unilever – C(Fees);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – SH(ST); Valeant Pharmaceuticals North America LLC – C(H);
  • Lawrence, Naomi, MD: no financial relationships exist with commercial interests.
  • Narurkar, Vic A., MD: Allergan, Inc. – A(Grants/Research Funding), I(Fees); Medicis Pharmaceutical Corporation – C(H); Merz Aesthetics – C(H); MyoScience – I(SO); Palomar Medical Technologies – I(Grants/Research Funding); Revance Therapeutics, Inc. – A(SO); Solta Medical – I(Grants/Research Funding);
  • Welsh, Kathleen M., MD: Allergan, Inc – A(H), SH(NC); Merz Aesthetics – A(H); Revance Therapeutics, Inc. – SH(NC);
Event Details
  • Date
    Monday, February 19
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 9
  • CME Credits
  • Type
  • Sue Ellen Cox, MD, FAAD
  • Andre Braz, MD
  • Annie Chiu, MD, FAAD
  • Kathleen M. Welsh, MD, FAAD
  • Kimberly J. Butterwick, MD, FAAD
  • Naomi Lawrence, MD, FAAD
  • Vic A. Narurkar, MD, FAAD